Literature DB >> 10712350

Tenascin mRNA expression at the foci of recent injury in usual interstitial pneumonia.

P Pääkkö1, R Kaarteenaho-Wiik, R Pöllänen, Y Soini.   

Abstract

To elucidate which cells are synthesizing tenascin in usual interstitial pneumonia (UIP) we have analyzed thoracoscopic or open lung biopsies from 30 patients with UIP by mRNA in situ hybridization, using (35)S-labeled tenascin RNA probes. The phenotype of the cells expressing tenascin mRNA was confirmed by immunohistochemical stainings of serial sections with antibodies against alpha-smooth muscle actin and human cytokeratin. The results demonstrate that tenascin is expressed at the foci of recent lesions consisting of intralumenal or incorporating loose fibrotic buds. The cells expressing tenascin mRNA were located in and underneath the newly formed epithelium. Immunohistochemical stainings showed that the cells in the newly formed epithelium were strongly cytokeratin positive, and thus evidently regenerating type 2 pneumocytes, while the cells underneath the newly formed epithelium were alpha-smooth muscle actin positive and apparently myofibroblasts. Tenascin mRNA expression was clearly stronger and more frequent in myofibroblasts than in type 2 pneumocytes, however. Weak tenascin mRNA expression was also found in metaplastic bronchiolar-type epithelium and alveolar macrophages. Our results are thus in good agreement with the previous studies showing that tenascin is actively synthesized at the early fibrotic lesions in UIP. Furthermore, results demonstrate that the interaction between the epithelium and the underlying connective tissue plays a significant role in tenascin synthesis and that myofibroblasts are mainly responsible for its synthesis in fibroblastic foci of UIP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712350     DOI: 10.1164/ajrccm.161.3.9809115

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

Review 1.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Tenascin-C deficiency attenuates TGF-ß-mediated fibrosis following murine lung injury.

Authors:  William A Carey; Glen D Taylor; Willow B Dean; James D Bristow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-10       Impact factor: 5.464

3.  Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.

Authors:  Vladislav A Dolgachev; Matthew R Ullenbruch; Nicholas W Lukacs; Sem H Phan
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

4.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics.

Authors:  Patrick Flood-Page; Andrew Menzies-Gow; Simon Phipps; Sun Ying; Arun Wangoo; Mara S Ludwig; Neil Barnes; Douglas Robinson; A Barry Kay
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

5.  Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome.

Authors:  Sreedevi Avasarala; Fangfang Zhang; Guangliang Liu; Ruixue Wang; Steven D London; Lucille London
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

6.  Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD.

Authors:  Magnus Löfdahl; Riitta Kaarteenaho; Elisa Lappi-Blanco; Göran Tornling; Magnus C Sköld
Journal:  Respir Res       Date:  2011-04-15

Review 7.  The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source.

Authors:  Ivana Mižíková; Rory E Morty
Journal:  Front Med (Lausanne)       Date:  2015-12-23

8.  Host Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals.

Authors:  Jacqueline M Achkar; Laetitia Cortes; Pascal Croteau; Corey Yanofsky; Marija Mentinova; Isabelle Rajotte; Michael Schirm; Yiyong Zhou; Ana Paula Junqueira-Kipnis; Victoria O Kasprowicz; Michelle Larsen; René Allard; Joanna Hunter; Eustache Paramithiotis
Journal:  EBioMedicine       Date:  2015-07-30       Impact factor: 8.143

9.  Myofibroblast expression in airways and alveoli is affected by smoking and COPD.

Authors:  Henna M Karvonen; Siri T Lehtonen; Terttu Harju; Raija T Sormunen; Elisa Lappi-Blanco; Johanna M Mäkinen; Kirsi Laitakari; Shirley Johnson; Riitta L Kaarteenaho
Journal:  Respir Res       Date:  2013-08-11

10.  JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers.

Authors:  Jos L J van der Velden; Ying Ye; James D Nolin; Sidra M Hoffman; David G Chapman; Karolyn G Lahue; Sarah Abdalla; Peng Chen; Yong Liu; Brydon Bennett; Nasreen Khalil; Donna Sutherland; William Smith; Gerald Horan; Mahmoud Assaf; Zebulun Horowitz; Rajesh Chopra; Randall M Stevens; Maria Palmisano; Yvonne M W Janssen-Heininger; Peter H Schafer
Journal:  Clin Transl Med       Date:  2016-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.